18F-FDG labelling of human leukocytes

L. A. Forstrom, B. P. Mullan, J. C. Hung, Val Lowe, L. M. Thorson

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Radiolabelled leukocytes are useful for the imaging of inflammation and infection, and 18F-fluorodeoxyglucose (18F-FDG) is known to concentrate in metabolically active cells. We evaluated the feasibility of leukocyte labelling with 18F-FDG using ACD and heparin anticoagulants at 20°C and 37°C, with and without gentle mixing during incubation. With leukocytes (WBC) harvested from 20 ml blood, studies were performed using 18F-FDG in concentrations of 3.7-74 MBq (0.1-2.0 mCi). 18F-FDG WBC stability in platelet-poor plasma was assessed at 1-4 h. Satisfactory labelling efficiency was achieved with incubation in heparin-saline at 37°C for 30 min (62.7±1.6%), and was further enhanced by mixing during incubation (78.1±3.9%). Cell labelling was predominantly of granulocytes (78.5±1.4%). 18F-FDG WBC was relatively stable in platelet-poor plasma for up to 4 h, and no cell staining was observed in viability studies using trypan blue. These results indicate the feasibility of leukocyte labelling with 18F-FDG, providing an approach that may be useful in PET imaging of inflammation and infection. (

Original languageEnglish (US)
Pages (from-to)691-694
Number of pages4
JournalNuclear Medicine Communications
Volume21
Issue number7
StatePublished - 2000

Fingerprint

Fluorodeoxyglucose F18
Leukocytes
Heparin
Blood Platelets
Inflammation
Trypan Blue
Infection
Granulocytes
Anticoagulants
Staining and Labeling

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Forstrom, L. A., Mullan, B. P., Hung, J. C., Lowe, V., & Thorson, L. M. (2000). 18F-FDG labelling of human leukocytes. Nuclear Medicine Communications, 21(7), 691-694.

18F-FDG labelling of human leukocytes. / Forstrom, L. A.; Mullan, B. P.; Hung, J. C.; Lowe, Val; Thorson, L. M.

In: Nuclear Medicine Communications, Vol. 21, No. 7, 2000, p. 691-694.

Research output: Contribution to journalArticle

Forstrom, LA, Mullan, BP, Hung, JC, Lowe, V & Thorson, LM 2000, '18F-FDG labelling of human leukocytes', Nuclear Medicine Communications, vol. 21, no. 7, pp. 691-694.
Forstrom LA, Mullan BP, Hung JC, Lowe V, Thorson LM. 18F-FDG labelling of human leukocytes. Nuclear Medicine Communications. 2000;21(7):691-694.
Forstrom, L. A. ; Mullan, B. P. ; Hung, J. C. ; Lowe, Val ; Thorson, L. M. / 18F-FDG labelling of human leukocytes. In: Nuclear Medicine Communications. 2000 ; Vol. 21, No. 7. pp. 691-694.
@article{db6312b63fd04741ae74f47e132c6389,
title = "18F-FDG labelling of human leukocytes",
abstract = "Radiolabelled leukocytes are useful for the imaging of inflammation and infection, and 18F-fluorodeoxyglucose (18F-FDG) is known to concentrate in metabolically active cells. We evaluated the feasibility of leukocyte labelling with 18F-FDG using ACD and heparin anticoagulants at 20°C and 37°C, with and without gentle mixing during incubation. With leukocytes (WBC) harvested from 20 ml blood, studies were performed using 18F-FDG in concentrations of 3.7-74 MBq (0.1-2.0 mCi). 18F-FDG WBC stability in platelet-poor plasma was assessed at 1-4 h. Satisfactory labelling efficiency was achieved with incubation in heparin-saline at 37°C for 30 min (62.7±1.6{\%}), and was further enhanced by mixing during incubation (78.1±3.9{\%}). Cell labelling was predominantly of granulocytes (78.5±1.4{\%}). 18F-FDG WBC was relatively stable in platelet-poor plasma for up to 4 h, and no cell staining was observed in viability studies using trypan blue. These results indicate the feasibility of leukocyte labelling with 18F-FDG, providing an approach that may be useful in PET imaging of inflammation and infection. (",
author = "Forstrom, {L. A.} and Mullan, {B. P.} and Hung, {J. C.} and Val Lowe and Thorson, {L. M.}",
year = "2000",
language = "English (US)",
volume = "21",
pages = "691--694",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - 18F-FDG labelling of human leukocytes

AU - Forstrom, L. A.

AU - Mullan, B. P.

AU - Hung, J. C.

AU - Lowe, Val

AU - Thorson, L. M.

PY - 2000

Y1 - 2000

N2 - Radiolabelled leukocytes are useful for the imaging of inflammation and infection, and 18F-fluorodeoxyglucose (18F-FDG) is known to concentrate in metabolically active cells. We evaluated the feasibility of leukocyte labelling with 18F-FDG using ACD and heparin anticoagulants at 20°C and 37°C, with and without gentle mixing during incubation. With leukocytes (WBC) harvested from 20 ml blood, studies were performed using 18F-FDG in concentrations of 3.7-74 MBq (0.1-2.0 mCi). 18F-FDG WBC stability in platelet-poor plasma was assessed at 1-4 h. Satisfactory labelling efficiency was achieved with incubation in heparin-saline at 37°C for 30 min (62.7±1.6%), and was further enhanced by mixing during incubation (78.1±3.9%). Cell labelling was predominantly of granulocytes (78.5±1.4%). 18F-FDG WBC was relatively stable in platelet-poor plasma for up to 4 h, and no cell staining was observed in viability studies using trypan blue. These results indicate the feasibility of leukocyte labelling with 18F-FDG, providing an approach that may be useful in PET imaging of inflammation and infection. (

AB - Radiolabelled leukocytes are useful for the imaging of inflammation and infection, and 18F-fluorodeoxyglucose (18F-FDG) is known to concentrate in metabolically active cells. We evaluated the feasibility of leukocyte labelling with 18F-FDG using ACD and heparin anticoagulants at 20°C and 37°C, with and without gentle mixing during incubation. With leukocytes (WBC) harvested from 20 ml blood, studies were performed using 18F-FDG in concentrations of 3.7-74 MBq (0.1-2.0 mCi). 18F-FDG WBC stability in platelet-poor plasma was assessed at 1-4 h. Satisfactory labelling efficiency was achieved with incubation in heparin-saline at 37°C for 30 min (62.7±1.6%), and was further enhanced by mixing during incubation (78.1±3.9%). Cell labelling was predominantly of granulocytes (78.5±1.4%). 18F-FDG WBC was relatively stable in platelet-poor plasma for up to 4 h, and no cell staining was observed in viability studies using trypan blue. These results indicate the feasibility of leukocyte labelling with 18F-FDG, providing an approach that may be useful in PET imaging of inflammation and infection. (

UR - http://www.scopus.com/inward/record.url?scp=0034230704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034230704&partnerID=8YFLogxK

M3 - Article

C2 - 10994674

AN - SCOPUS:0034230704

VL - 21

SP - 691

EP - 694

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 7

ER -